Recurrent cardiac drug-eluting stent thrombosis due to antiphospholipid syndrome: a case report.

ABSTRACT:

Background

Antiphospholipid syndrome (APS) is an immune-mediated thrombo-inflammatory disease that causes arterial and venous thromboembolic events. The European Society of Cardiology (ESC) recommends treating APS with warfarin, covering with low molecular weight heparin until the international normalized ratio (INR) is therapeutic. The aim of this case report was to bring attention of increased risk of acute thrombotic episodes in patients with APS.

Case description

We describe the case of a 69-year-old man with APS who developed recurrent stent thrombosis with subsequent myocardial injury, which led to acute heart failure. A failure to adequately anticoagulated might be contributed to recurrent thrombosis. In retrospect review of the case, one of the predisposing factors c

SUBMITTER: Lin KK 

PROVIDER: S-EPMC12593030 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature